Wellington Management Group
ADMA icon

Wellington Management Group’s ADMA Biologics ADMA Stock Holding History

Wellington Management Group’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$731K Sell
87,336
-7,877
-8% -$71.8K ﹤0.01% 1793
2026
Q1 		$858K Sell
95,213
-2,116
-2% -$33.4K ﹤0.01% 1705
2025
Q4 		$1.78M Sell
97,329
-5,974
-6% -$101K ﹤0.01% 1622
2025
Q3 		$1.51M Sell
103,303
-828,636
-89% -$14.2M ﹤0.01% 1704
2025
Q2 		$17M Buy
931,939
+838,118
+893% +$17.1M ﹤0.01% 1024
2025
Q1 		$1.86M Sell
93,821
-11,638
-11% -$201K ﹤0.01% 1576
2024
Q4 		$1.81M Sell
105,459
-13,834
-12% -$260K ﹤0.01% 1589
2024
Q3 		$2.38M Sell
119,293
-478,935
-80% -$7.45M ﹤0.01% 1504
2024
Q2 		$6.69M Sell
598,228
-14,530
-2% -$122K ﹤0.01% 1253
2024
Q1 		$4.04M Buy
612,758
+398,773
+186% +$2.18M ﹤0.01% 1372
2023
Q4 		$967K Buy
+213,985
New +$792K ﹤0.01% 1631

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Wellington Management Group's ADMA Position: Q2 2026 in Review

Wellington Management Group reduced its ADMA Biologics (ADMA) stake by 8.3% in Q2 2026, selling an estimated $71.8K and leaving 87,336 shares worth $731K. The position accounts for ﹤0.01% of the portfolio, ranked #1793.

Wellington Management Group first reported a position in ADMA in Q4 2023 and has held it in 11 quarters since. The position peaked at $17M in Q2 2025. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Wellington Management Group held 87,336 shares of ADMA Biologics worth $731K as of Q2 2026.
  • Wellington Management Group sold 7,877 ADMA Biologics shares in Q2 2026, an estimated $71.8K.
  • ADMA Biologics made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1793 holding.
  • Wellington Management Group first reported a position in ADMA Biologics in Q4 2023 and has held it in 11 quarters since.
  • Wellington Management Group's ADMA Biologics position peaked at $17M in Q2 2025.
  • 322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.